Ruijin Hospital, Shanghai Jiao Tong University
The hospital where all-trans retinoic acid and arsenic cured acute promyelocytic leukaemia, and still China's leading haematology centre.
Ruijin Hospital dates to 1907 and is home to the Shanghai Institute of Hematology, where Zhen-Yi Wang and Zhu Chen established differentiation therapy of acute promyelocytic leukaemia with all-trans retinoic acid and then arsenic trioxide, turning a lethal leukaemia into one of the most curable. The institute remains a global reference for APL, AML genomics and lymphoma, and hosts national CAR-T and haematopoietic transplant programmes. Ruijin is also a major centre for gastric cancer surgery, pancreatic surgery, endocrine tumours and burns, and runs one of Shanghai's proton therapy projects.
- Shanghai Institute of Hematology
- APL differentiation therapy
- Lymphoma
- Gastric and pancreatic surgery
- Proton therapy
Pages like this
not linked directly; found by shared links- InstitutionNational University Hospital / National University Cancer Institute, Singapore
Shares Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET), Acute myeloid leukaemia, Diffuse large B-cell lymphoma, Gastric & gastro-oesophageal junction cancer.
- PersonStephen J. Forman
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Proton therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- InstitutionSeoul St. Mary's Hospital
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- InstitutionHenan Cancer Hospital
Shares Diffuse large B-cell lymphoma, Gastric & gastro-oesophageal junction cancer, CAR-T cell therapy.
- TermDifferentiation syndrome
Shares Arsenic trioxide, Tretinoin (all-trans retinoic acid, ATRA), Acute myeloid leukaemia.
- InstitutionUniversity Cancer Center Frankfurt (UCT)
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- IdeaPublic-sector CAR-T manufacturing in India, Brazil and South Africa under $50,000
Shares Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.